📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance. (2020)

First Author: Orgaz JL

Attributed to: Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ccell.2019.12.003

PubMed Identifier: 31935375

Publication URI: http://europepmc.org/abstract/MED/31935375

Type: Journal Article/Review

Volume: 37

Parent Publication: Cancer cell

Issue: 1

ISSN: 1535-6108